Filana Therapeutics (FLNA) Net Equity Issued and Repurchased (2011 - 2022)
Filana Therapeutics (FLNA) posted quarterly Net Equity Issued and Repurchased of $47.3 million for Q4 2022, down 75.07% quarter-over-quarter from $189.8 million in Q1 2021.
Filana Therapeutics (FLNA) Net Equity Issued and Repurchased (2011 - 2022) Analysis & Trends
Filana Therapeutics' Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at $47.3 million for Q4 2022.
- In Q4 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $47.3 million; the TTM figure through Dec 2022 stood at $47.3 million (down 75.07% YoY), while the FY2022 annual figure was $47.3 million, down 75.07% from the prior year.
- Net Equity Issued and Repurchased for Q4 2022 stood at $47.3 million, down from $189.8 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $189.8 million in Q1 2021, with the low at -$72000.0 in Q4 2018.
- The 3-year median for Net Equity Issued and Repurchased is $2.0 million (2018), against an average of $48.2 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 47.33 Mn |
| Dec 31, 2022 | 47.33 Mn |
| Mar 31, 2021 | 189.83 Mn |
| Mar 31, 2021 | 189.83 Mn |
| Dec 31, 2018 | -72,000.00 |
| Dec 31, 2018 | -72,000.00 |
| Sep 30, 2018 | 2.00 Mn |
| Sep 30, 2018 | 2.00 Mn |
| Mar 31, 2018 | 1.90 Mn |
| Mar 31, 2018 | 1.90 Mn |
| Jun 30, 2014 | 313,000.00 |
| Jun 30, 2014 | 313,000.00 |
| Mar 31, 2014 | 66,000.00 |
| Mar 31, 2014 | 66,000.00 |
| Dec 31, 2013 | 264,000.00 |
| Dec 31, 2013 | 264,000.00 |
| Jun 30, 2013 | 254,000.00 |
| Jun 30, 2013 | 254,000.00 |
| Mar 31, 2013 | 6,000.00 |
| Mar 31, 2013 | 6,000.00 |